Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER2+ Cancer”

3,734 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,734 results

Very early researchStudy completedNCT04130152
What this trial is testing

Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 22
Not applicableStudy completedNCT03590938
What this trial is testing

Lynparza Breast Cancer Clinical Experience Investigation

Who this might be right for
Breast Cancer
AstraZeneca 111
Testing effectiveness (Phase 2)Study completedNCT03659136
What this trial is testing

The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 103
Testing effectiveness (Phase 2)Study completedNCT00337649
What this trial is testing

Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 27
Testing effectiveness (Phase 2)Study completedNCT00301899
What this trial is testing

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

Who this might be right for
Breast Cancer
National Institutes of Health Clinical Center (CC) 37
Large-scale testing (Phase 3)Study completedNCT00103233
What this trial is testing

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT00386685
What this trial is testing

XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Testing effectiveness (Phase 2)WithdrawnNCT00678626
What this trial is testing

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Who this might be right for
Breast Cancer
Pfizer
Early research (Phase 1)Study completedNCT01632332
What this trial is testing

Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerStage II Breast Cancer+3 more
Mayo Clinic 22
Large-scale testing (Phase 3)Study completedNCT03556358
What this trial is testing

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer+2 more
Tanvex BioPharma USA, Inc. 809
Testing effectiveness (Phase 2)Looking for participantsNCT05671822
What this trial is testing

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

Who this might be right for
HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 258
Not applicableUnknownNCT05165602
What this trial is testing

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

Who this might be right for
HER2 Positive Gastric Cancer
Peking University 30
Testing effectiveness (Phase 2)Study completedNCT00526045
What this trial is testing

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerHematologic Neoplasms
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Looking for participantsNCT07176312
What this trial is testing

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Who this might be right for
Gastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Post-approval studies (Phase 4)UnknownNCT03799692
What this trial is testing

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

Who this might be right for
HER-2 Negative Breast Cancer
Fudan University 78
Testing effectiveness (Phase 2)Study completedNCT00777049
What this trial is testing

Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Translational Research in Oncology 54
Not applicableLooking for participantsNCT06299852
What this trial is testing

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerOligometastatic Disease
N.N. Petrov National Medical Research Center of Oncology 58
Testing effectiveness (Phase 2)Study completedNCT02362958
What this trial is testing

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Who this might be right for
HER2 Positive Breast Cancer
Sun Yat-sen University 159
Testing effectiveness (Phase 2)WithdrawnNCT02336984
What this trial is testing

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Load More Results